Abstract

P033 Risk of Crohn’s disease-related hospitalization in patients receiving long-term adalimumab therapy: 3-year data from CHARM and ADHERE E.V. Loftus Jr.1 *, B. Feagan2, N. Chen3, P. Mulani3, J. Chao3. 1Miles & Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, MN, USA, 2Robarts Research Institute, University of Western Ontario, London, ON, Canada, 3Abbott Laboratories, Abbott Park, IL, USA

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call